Vivos Therapeutics, Inc. Stock

Equities

VVOS

US92859E2072

Medical Equipment, Supplies & Distribution

Delayed Nasdaq 09:45:18 2024-05-24 am EDT 5-day change 1st Jan Change
2.06 USD -1.41% Intraday chart for Vivos Therapeutics, Inc. -10.02% -83.44%
Sales 2024 * 14.9M Sales 2025 * 18.41M Capitalization 6.23M
Net income 2024 * -12M Net income 2025 * -10M EV / Sales 2024 * 0.42 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.34 x
P/E ratio 2024 *
-0.5 x
P/E ratio 2025 *
-0.92 x
Employees 119
Yield 2024 *
-
Yield 2025 *
-
Free-Float 93.75%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.88%
1 week-7.52%
Current month-17.39%
1 month-21.13%
3 months-57.35%
6 months-47.62%
Current year-83.20%
More quotes
1 week
2.04
Extreme 2.04
2.28
1 month
1.96
Extreme 1.9601
2.70
Current year
1.96
Extreme 1.9601
12.75
1 year
1.96
Extreme 1.9601
48.79
3 years
1.96
Extreme 1.9601
177.25
5 years
1.96
Extreme 1.9601
360.25
10 years
1.96
Extreme 1.9601
360.25
More quotes
Managers TitleAgeSince
Founder - 16-07-06
Founder - 16-07-06
Founder - 16-07-06
Members of the board TitleAgeSince
Director/Board Member 67 20-05-31
Director/Board Member 61 20-05-31
Director/Board Member 56 20-05-31
More insiders
Date Price Change Volume
24-05-24 2.06 -1.41% 1 477
24-05-23 2.09 -1.88% 21,400
24-05-22 2.13 -3.18% 32,800
24-05-21 2.2 -1.79% 25,144
24-05-20 2.24 -2.18% 26,828

Delayed Quote Nasdaq, May 23, 2024 at 03:59 pm EDT

More quotes
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.09 USD
Average target price
7.325 USD
Spread / Average Target
+250.48%
Consensus